Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-04-12 00:00:00 ET · period of report 2024-04-10 · accession 0001048477-24-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-12 | 2024-04-10 | BMRN | Burkhart Erin | CAO, GVP | S - Sale | $90.00 | -2,286 | 16.2K | -12% | -$205.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-10 | S | D | 2,286 | $90.00 | 16,156 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on November 29, 2023. |